• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 1/14/25: Simpler Sample Ordering for HCPs, Smart Money Bets on Value & more

News
Article

The latest news for pharma industry insiders.

Making Sample Ordering Simpler for HCPs

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Mark Jara, founder and CTO, RxS, explains the value of an online portal that offers logistics flexibility.

Smart Money Bets on Value | Predictions for 2025

Kimberly Westrich, M.A., chief strategy officer of National Pharmaceutical Council, shares her prediction for 2025.

Biden Administration Adopts Rules to Guide AI’s Global Spread

New rules aim to keep advanced technology out of China and to ensure that cutting-edge artificial intelligence is developed by the United States and its allies.

Avanzanite Bioscience Announces Appointment of Chief Technical Officer to Accelerate European Expansion and Drive Growth

Avanzanite Bioscience B.V. announced the appointment of Jason Cameron as Chief Technical Officer. This move marks a significant step in Avanzanite’s mission to accelerate growth, expand its presence in Europe, and advance the company’s next phase of international partnerships and product launches.

Laura Wegner on LinkedIn

In a recent interview with Michael Wong, published in the Pharmaceutical Executive, I shared my thoughts on the importance of communication in building effective teams and navigating the complexities of healthcare technology. I reflected on the challenges of scaling Mii and how regular, honest, and detailed communication became essential for keeping the team aligned and working toward shared goals.
You can read the article here: https://lnkd.in/eDdiVU_p

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs